AQP8 | Aquaporin 8 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARL14 | ADP-ribosylation factor-like 14 | Predicted intracellular proteins
| | | | | Group enriched |
ASAH2 | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ASAH2B | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B | Predicted intracellular proteins
| | | | | Group enriched |
ASIC5 | Acid-sensing (proton-gated) ion channel family member 5 | Predicted membrane proteins
| | | | | Group enriched |
ATOH1 | Atonal homolog 1 (Drosophila) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
ATP10B | ATPase, class V, type 10B | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP4A | ATPase, H+/K+ exchanging, alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP4B | ATPase, H+/K+ exchanging, beta polypeptide | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
B3GALT1 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT6 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT8 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT2 | Beta-1,4-N-acetyl-galactosaminyl transferase 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
B4GALNT3 | Beta-1,4-N-acetyl-galactosaminyl transferase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BACE2 | Beta-site APP-cleaving enzyme 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BAIAP2L2 | BAI1-associated protein 2-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BARX1 | BARX homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
BCAS1 | Breast carcinoma amplified sequence 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BCL2L15 | BCL2-like 15 | Predicted intracellular proteins
| | | | | Group enriched |
BCO1 | Beta-carotene oxygenase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BEST2 | Bestrophin 2 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BRINP3 | Bone morphogenetic protein/retinoic acid inducible neural-specific 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BTNL2 | Butyrophilin-like 2 (MHC class II associated) | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BTNL3 | Butyrophilin-like 3 | Predicted membrane proteins
| | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
C11orf86 | Chromosome 11 open reading frame 86 | Predicted intracellular proteins
| | | | | Group enriched |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted secreted proteins
| | | | | Group enriched |
C17orf78 | Chromosome 17 open reading frame 78 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
C1orf106 | Chromosome 1 open reading frame 106 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf195 | Chromosome 1 open reading frame 195 | Predicted intracellular proteins
| | | | | Group enriched |
C2orf70 | Chromosome 2 open reading frame 70 | Predicted intracellular proteins
| | | | | Group enriched |
C2orf72 | Chromosome 2 open reading frame 72 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C6orf222 | Chromosome 6 open reading frame 222 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C6orf58 | Chromosome 6 open reading frame 58 | Predicted secreted proteins
| | | | | Group enriched |
C8G | Complement component 8, gamma polypeptide | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
C9orf152 | Chromosome 9 open reading frame 152 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CA13 | Carbonic anhydrase XIII | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA7 | Carbonic anhydrase VII | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Group enriched |